177 results on '"Vallone C"'
Search Results
152. Impact of kidney transplant morbidity on elderly recipients' outcomes.
- Author
-
Pravisani R, Isola M, Baccarani U, Crestale S, Tulissi P, Vallone C, Risaliti A, Cilloni D, and Adani GL
- Subjects
- Aged, Graft Rejection, Graft Survival, Humans, Morbidity, Retrospective Studies, Risk Factors, Kidney Failure, Chronic, Kidney Transplantation adverse effects
- Abstract
Background and Aims: Nowadays, advanced age does not represent an absolute contraindication to kidney transplantation (KT). However, aging is frequently associated with multiple comorbidities and lower performance status, making KT candidates less surgically fit. Limited data are available on the impact of KT morbidity on elderly recipients' outcomes., Methods: Retrospective study on a single center cohort of 130 KT recipients over 65 years old, representing 16.2% of KT clinical series, during the period 2000-2018. Number and severity of comorbidities were evaluated with the Charlson Comorbidity index (CCI)., Results: The median age at transplantation was 67 [IQR66-71] years and median CCI was 5 [IQR4-6]. The prevalence of postoperative complications with a Clavien-Dindo (C-D) severity score > 2 was 29%. Increasing age did not predict KT morbidity in terms of C-D score > 2, infectious, respiratory, cardiologic, urologic or vascular complications, delayed graft function, symptomatic lymphocele, bleeding, acute or chronic rejection. Conversely, CCI score was a predictor of overall complications with C-D score > 2, cardiologic, respiratory and vascular complications, and bleeding. Among others, CCI score, post-KT cardiologic complications, C-D score > 2 were identified as significant predictors of both early mortality and graft loss in univariate analysis. Increasing recipient age did not correlate with graft loss risk and graft loss did not impact patient survival. C-D score > 2 was a predictor of poor survival even in multivariate analysis., Conclusions: Elderly recipients showed a significant vulnerability to KT morbidity which correlates with CCI. While graft loss did not impact recipient survival, severe postoperative complications (C-D > 2) were independently associated increased mortality.
- Published
- 2021
- Full Text
- View/download PDF
153. The Interplay between CD27 dull and CD27 bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory.
- Author
-
Grimsholm O, Piano Mortari E, Davydov AN, Shugay M, Obraztsova AS, Bocci C, Marasco E, Marcellini V, Aranburu A, Farroni C, Silvestris DA, Cristofoletti C, Giorda E, Scarsella M, Cascioli S, Barresi S, Lougaris V, Plebani A, Cancrini C, Finocchi A, Moschese V, Valentini D, Vallone C, Signore F, de Vincentiis G, Zaffina S, Russo G, Gallo A, Locatelli F, Tozzi AE, Tartaglia M, Chudakov DM, and Carsetti R
- Subjects
- Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Gene Expression Profiling, Humans, Immunoglobulin Class Switching genetics, Immunoglobulin Variable Region genetics, Infant, Infant, Newborn, Middle Aged, Models, Immunological, Pregnancy, Somatic Hypermutation, Immunoglobulin genetics, Tissue Donors, Transcription, Genetic, B-Lymphocytes immunology, Immunologic Memory genetics, Tumor Necrosis Factor Receptor Superfamily, Member 7 metabolism
- Abstract
Memory B cells (MBCs) epitomize the adaptation of the immune system to the environment. We identify two MBC subsets in peripheral blood, CD27
dull and CD27bright MBCs, whose frequency changes with age. Heavy chain variable region (VH) usage, somatic mutation frequency replacement-to-silent ratio, and CDR3 property changes, reflecting consecutive selection of highly antigen-specific, low cross-reactive antibody variants, all demonstrate that CD27dull and CD27bright MBCs represent sequential MBC developmental stages, and stringent antigen-driven pressure selects CD27dull into the CD27bright MBC pool. Dynamics of human MBCs are exploited in pregnancy, when 50% of maternal MBCs are lost and CD27dull MBCs transit to the more differentiated CD27bright stage. In the postpartum period, the maternal MBC pool is replenished by the expansion of persistent CD27dull clones. Thus, the stability and flexibility of human B cell memory is ensured by CD27dull MBCs that expand and differentiate in response to change., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
154. Effects of Delayed Hypothermic Machine Perfusion on Kidney Grafts with a Preliminary Period of Static Cold Storage and a Total Cold Ischemia Time of Over 24 Hours.
- Author
-
Adani GL, Pravisani R, Crestale S, Baccarani U, Scott CA, D'Alì L, DeMaglio G, Tulissi P, Vallone C, Isola M, Righi E, Pizzolito S, Di Loreto C, and Risaliti A
- Subjects
- Aged, Female, Hemodynamics physiology, Humans, Male, Middle Aged, Organ Preservation methods, Perfusion, Time Factors, Treatment Outcome, Vascular Resistance physiology, Cold Ischemia, Cryopreservation methods, Graft Survival physiology, Hypothermia, Induced methods, Kidney, Kidney Transplantation methods
- Abstract
BACKGROUND Hypothermic machine perfusion (HMP) appears to exert a reconditioning effect on the ischemic damage of kidney grafts. However, some concerns still remain about its real effectiveness when it is delayed after a preliminary period of static cold storage (SCS) or with prolonged overall cold ischemia time (CIT). MATERIAL AND METHODS The effect of HMP on hemodynamic, metabolic, histological and ultrastructural features of grafts was investigated in 21 single-kidney grafts treated with a delayed HMP after SCS and with a total CIT of over 24 h. RESULTS The mean CIT, SCS, and HMP times were 29 h, 12 h, and 18 h, respectively. Longer SCS was associated with higher vascular resistance and lower arterial flow. In the pre- vs. post-HMP comparison, a significant decrease in arterial resistances and increase of flow were recorded. The hemodynamic improvement was independent of HMP duration. The perfused grafts retained some metabolic activity, with a statistically significant decrease of pH, pO2, and glucose levels, and increase of lactates in the perfusion liquid, by the end of HMP. Longer SCS was associated with higher pH and greater pO2 decrease during HMP. Light microscopy and transmission electronic microscopy revealed no significant variations in nuclear, cytoplasmic, or ultrastructural damage. SCS, HMP, and CIT were not identified as risk factor for delayed graft function or rejection. CONCLUSIONS A delayed and extended HMP can recover the graft hemodynamic function, maintain some metabolic activity, and stabilize the accumulated ischemic damage due to a preliminary SCS.
- Published
- 2020
- Full Text
- View/download PDF
155. Risk Factors for Graft Loss Due to Acute Vascular Complications in Adult Renal Transplantation Using Grafts Without Vascular Anomalies.
- Author
-
Adani GL, Pravisani R, Baccarani U, Faion M, Crestale S, Tulissi P, Vallone C, and Risaliti A
- Subjects
- Adult, Case-Control Studies, Female, Humans, Male, Middle Aged, Postoperative Complications epidemiology, Prevalence, Retrospective Studies, Risk Factors, Vascular Diseases epidemiology, Graft Survival physiology, Kidney Transplantation adverse effects, Postoperative Complications etiology, Vascular Diseases etiology
- Abstract
Background: Vascular complications are the main cause of early graft loss in renal transplant (RT). A graft with multiple vessels represents the most validated risk factor. The aim of the present study was to identify potential predictive factors for acute vascular complications causing graft loss when graft vascular anomalies are excluded., Methods: This is a retrospective case-control (1:3 ratio) study extrapolated from the RT series of the Renal Transplant Unit - Udine University Hospital, during the period 1993-2017. Grafts with multiple vessels and retransplant cases were excluded., Results: The overall prevalence of graft loss due to acute vascular complications was 2.6% (25/961). Seventeen complicated recipients had grafts without vascular anomalies (case group). The median time between RT and complication was 6 days (interquartile range, 4-23 days). The following types of vascular complications were recorded: 5 isolated renal artery thromboses (0.5%), 4 isolated renal vein thromboses (0.4%), 4 combined renal artery and vein thromboses (0.3%), 3 renal artery ruptures due to mycotic arteritis (0.3%), and 1 renal artery nonmycotic pseudoaneurysm (0.1%). No differences were recorded between the groups in terms of donors and grafts characteristics. Complicated recipients showed a statistically higher prevalence of thromboembolism history (P = .046) and vascular atherosclerosis (P = .048). During the postoperative course, blood stream infections (P = .02), acute rejection (P = .03), bleeding from a nonmacrovascular source (P = .04), and multiple reintervention because of nonvascular complications (P = .03) were identified as significant risk factors., Conclusions: Recipient characteristics and post-RT complications rather than donor and graft characteristics are relevant risk factors for graft loss due to acute vascular complications when graft vascular anomalies are excluded., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
156. Maternal Intake of n-3 Polyunsaturated Fatty Acids During Pregnancy Is Associated With Differential Methylation Profiles in Cord Blood White Cells.
- Author
-
Bianchi M, Alisi A, Fabrizi M, Vallone C, Ravà L, Giannico R, Vernocchi P, Signore F, and Manco M
- Abstract
A healthy diet during pregnancy is pivotal for the offspring health at birth and later in life. N-3 polyunsaturated fatty acids (n-3 PUFAs) are not endogenously produced in humans and are exclusively derived from the diet. They are pivotal for the fetus growth and neuronal development and seem beneficial in reducing the risk of cardiometabolic diseases and preventing later allergic disorders in the offspring by modulating the inflammatory immune response. In the present study, we investigated the association between maternal intakes of n-3PUFAs, profiled on maternal erythrocyte membranes at pregnancy term, and offspring DNA methylation on cord blood mononuclear cells in a sample of 118 mother-newborn pairs randomly drawn from the "Feeding fetus' low-grade inflammation and insulin-resistance" study cohort. N-3 PUFA content on erythrocyte membranes is a validated biomarker to measure objectively medium term intake of n-3 PUFAs. Based on distribution of n-3 PUFA in the whole cohort of mothers, we identified mothers with low (n-3 PUFA concentration <25th percentile), medium (n-3 PUFAs between 25th and 75th percentiles), and high n-3 PUFA content (>75th percentile). The HumanMethylation450 BeadChip (Illumina) was used for the epigenome-wide association study using the Infinium Methylation Assay. The overall DNA methylation level was not different between the three groups while there was significant difference in methylation levels at certain sites. Indeed, 8,503 sites had significantly different methylations between low and high n-3 PUFA groups, 12,716 between low and medium n-3 PUFA groups, and 18,148 between high and medium n-3 PUFA groups. We found differentially methylated genes that belong prevalently to pathways of signal transduction, metabolism, downstream signaling of G protein-coupled receptors, and gene expression. Within these pathways, we identified four differentially methylated genes, namely, MSTN, IFNA13, ATP8B3, and GABBR2, that are involved in the onset of insulin resistance and adiposity, innate immune response, phospholipid translocation across cell membranes, and mechanisms of addiction to high fat diet, alcohol, and sweet taste. In conclusion, findings of this preliminary investigation suggest that maternal intake of n-3 PUFAs during pregnancy has potential to influence the offspring DNA methylation. Validation of results in a larger cohort and investigation of biological significance and impact on the phenotype are warranted., (Copyright © 2019 Bianchi, Alisi, Fabrizi, Vallone, Ravà, Giannico, Vernocchi, Signore and Manco.)
- Published
- 2019
- Full Text
- View/download PDF
157. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience.
- Author
-
Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, and Signore F
- Subjects
- Delivery Rooms, Female, Gastroschisis diagnostic imaging, Gastroschisis mortality, Gestational Age, Humans, Infant, Newborn, Length of Stay, Male, Parenteral Nutrition, Pregnancy, Retrospective Studies, Survival Rate, Time Factors, Treatment Outcome, Ultrasonography, Prenatal, Gastroschisis surgery
- Abstract
Gastroschisis is a congenital abdominal wall defect and its management remains an issue. We performed a review of the literature to summarize its evaluation, management and outcome and we describe a new type of surgical reduction performed in our center without anesthesia (GA), immediately after birth, in the delivery room. Between January 2002 and March 2013, we enrolled all live born infants with gastroschisis referred to the third-level Division of Obstetrics and Gynecology "San Camillo" of Rome. Two groups of infants were identified: group 1 in which gastroschis reduction was performed by the traditional technique and group 2 in which reduction was immediately performed after birth in the delivery room without GA. Twelve infants were enrolled in group 1, and seven infants in group 2. Statistical significance was observed between the groups regarding the hospital stay, for the duration of parenteral nutrition and full oral feeds (p = .004). Survival was similar between two groups. The reduction without GA performed immediately after birth in a delivery room encourages the relationship between the mother and her child and appears to be a safe and feasible technique in a selected group of patients with simple gastroschisis defect; for this reason, it could represent a valid alternative to traditional approach.
- Published
- 2018
- Full Text
- View/download PDF
158. Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study.
- Author
-
Gallo A, Vallone C, Sabatelli L, Ventura G, Covino M, Cammarota G, Gasbarrini A, Landolfi R, and Montalto M
- Subjects
- Aged, Aged, 80 and over, Biomarkers analysis, Clostridioides difficile drug effects, Diarrhea drug therapy, Feces chemistry, Female, Humans, Inflammation drug therapy, Longitudinal Studies, Male, Middle Aged, Recurrence, Severity of Illness Index, Time Factors, Anti-Bacterial Agents therapeutic use, Clostridium Infections drug therapy, Clostridium Infections mortality, Leukocyte L1 Antigen Complex analysis, Proton Pump Inhibitors therapeutic use
- Abstract
Background: Clostridium difficile infection (CDI) is characterized by a relevant intestinal neutrophil infiltrate. So far, role of fecal calprotectin in CDI, has been investigated only in few studies, mainly focused on diagnosis of the disease., Aim: By a longitudinal design, we assess fecal calprotectin concentrations (FCCs) in subjects with CDI, evaluating the correlation between fecal marker and response to therapy., Methods: Clinical (diarrhea scoring) and laboratory (FCCs and leucocytes count) evaluation was performed in 56 subjects with CDI at time of diagnosis (T
0 ) and after a week from starting of therapy (T1 ). Clinical response to therapy at T1 was related with both T0 and T1 FCC values. FCCs were also related to all-cause 30-day mortality, recurrence and death, both of them within 90 days., Results: FCCs at T1 were significantly increased in subjects with persistence of diarrhea in respect to the other ones (285.5 ± 270 µg/g vs 150.7 ± 147 µg/g, respectively; p < .05). Patients who did not respond to therapy showed higher, but not significative, FCCs at T0 than patients who responded. No correlation was found among FCCs, both at T0 and T1 , and the other outcomes., Conclusions: Longitudinal evaluation of FCCs in patients with CDI could support physicians in clinical management of disease, for example in term of duration (10 vs 14 days) or type (first vs second line therapy). Further and larger studies could confirm the eventual role of this marker in prognostic algorithms, mainly in prediction of recurrence.- Published
- 2018
- Full Text
- View/download PDF
159. Non-Coding RNAs and Endometrial Cancer.
- Author
-
Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, Nucciotti R, Costantini FM, Piergentili R, Putignani L, and Signore F
- Abstract
Non-coding RNAs (ncRNAs) are involved in the regulation of cell metabolism and neoplastic transformation. Recent studies have tried to clarify the significance of these information carriers in the genesis and progression of various cancers and their use as biomarkers for the disease; possible targets for the inhibition of growth and invasion by the neoplastic cells have been suggested. The significance of ncRNAs in lung cancer, bladder cancer, kidney cancer, and melanoma has been amply investigated with important results. Recently, the role of long non-coding RNAs (lncRNAs) has also been included in cancer studies. Studies on the relation between endometrial cancer (EC) and ncRNAs, such as small ncRNAs or micro RNAs (miRNAs), transfer RNAs (tRNAs), ribosomal RNAs (rRNAs), antisense RNAs (asRNAs), small nuclear RNAs (snRNAs), Piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), competing endogenous RNAs (ceRNAs), lncRNAs, and long intergenic ncRNAs (lincRNAs) have been published. The recent literature produced in the last three years was extracted from PubMed by two independent readers, which was then selected for the possible relation between ncRNAs, oncogenesis in general, and EC in particular., Competing Interests: The authors declare no conflict of interest.
- Published
- 2018
- Full Text
- View/download PDF
160. Association between Maternal and Foetal Erythrocyte Fatty Acid Profiles and Birth Weight.
- Author
-
Cinelli G, Fabrizi M, Ravà L, Signore F, Vernocchi P, Semeraro M, Vallone C, Lanciotti R, Ciofi Degli Atti M, and Manco M
- Subjects
- Adult, Fatty Acids adverse effects, Fatty Acids, Omega-6 blood, Female, Gestational Age, Humans, Infant, Newborn, Maternal Nutritional Physiological Phenomena, Nutritional Status, Pregnancy, Risk Factors, Birth Weight, Erythrocytes metabolism, Fatty Acids blood, Fetal Blood metabolism, Infant, Small for Gestational Age
- Abstract
Regular foetal development is crucial for assuring good health status in the offspring. The quality and quantity of maternal dietary fatty acids (FAs) can affect growth. The study aimed to: (1) investigate the association of maternal/foetal lipid profiles with birth weight (BW); and (2) compare these profiles in small, appropriate, and large for gestational age (SGA, AGA, and LGA) infants. FAs were measured in erythrocyte membranes using gas chromatography analysis in 607 mother-infant pairs (316 males, 52.1%). In the quantile regression, a significant association between BW and levels of maternal linoleic acid (LA; C18:2, n-6; coefficient: 18.66; p = 0.010), arachidonic acid (AA; C20:4, n-6; coefficient: 11.35; p = 0.007), docosahexaenoic acid (DHA; C22:6, n-3; coefficient: 29.73; p = 0.007), polyunsaturated FAs (coefficient: 8.55; p = 0.001), foetal DHA (coefficient: -22.82; p = 0.037), and saturated FAs (coefficient: -65.41; p = 0.002) was found. Myristic (C14:0) and pentadecanoic acids (C15:0), both maternal ( p = 0.000; p = 0.017) and foetal ( p = 0.009; p = 0.002), and maternal erucic acid (C22:1, n-9; p = 0.026) were found at higher levels in SGA infants as compared to AGA ones. Conversely, maternal LA, AA, and omega 6 FAs levels were higher in AGA infants ( p = 0.037; p = 0.003; p = 0.026, respectively). Maternal and foetal polyunsaturated and omega 6 FAs levels are positively related to BW, while a lipid profile rich in saturated FAs and erucic acid may influence the risk of SGA., Competing Interests: The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.
- Published
- 2018
- Full Text
- View/download PDF
161. Influence of Maternal Obesity and Gestational Weight Gain on Maternal and Foetal Lipid Profile.
- Author
-
Cinelli G, Fabrizi M, Ravà L, Ciofi Degli Atti M, Vernocchi P, Vallone C, Pietrantoni E, Lanciotti R, Signore F, and Manco M
- Subjects
- 8,11,14-Eicosatrienoic Acid blood, Adolescent, Adult, Arachidonic Acid blood, Birth Weight, Body Mass Index, Docosahexaenoic Acids blood, Educational Status, Eicosapentaenoic Acid blood, Erythrocytes chemistry, Female, Fetal Blood chemistry, Humans, Infant, Newborn, Linoleic Acid blood, Male, Middle Aged, Mothers, Pregnancy, Young Adult, alpha-Linolenic Acid blood, Fatty Acids blood, Fetus chemistry, Obesity physiopathology, Weight Gain
- Abstract
Fatty acids (FAs) are fundamental for a foetus's growth, serving as an energy source, structural constituents of cellular membranes and precursors of bioactive molecules, as well as being essential for cell signalling. Long-chain polyunsaturated FAs (LC-PUFAs) are pivotal in brain and visual development. It is of interest to investigate whether and how specific pregnancy conditions, which alter fatty acid metabolism (excessive pre-pregnancy body mass index (BMI) or gestational weight gain (GWG)), affect lipid supply to the foetus. For this purpose, we evaluated the erythrocyte FAs of mothers and offspring (cord-blood) at birth, in relation to pre-pregnancy BMI and GWG. A total of 435 mothers and their offspring (237 males, 51%) were included in the study. Distribution of linoleic acid (LA) and α-linolenic acid (ALA), and their metabolites, arachidonic acid, dihomogamma linoleic (DGLA) and ecosapentanoic acid, was significantly different in maternal and foetal erythrocytes. Pre-pregnancy BMI was significantly associated with maternal percentage of MUFAs (Coeff: -0.112; p = 0.021), LA (Coeff: -0.033; p = 0.044) and DHA (Coeff. = 0.055; p = 0.0016); inadequate GWG with DPA (Coeff: 0.637; p = 0.001); excessive GWG with docosaexahenoic acid (DHA) (Coeff. = -0.714; p = 0.004). Moreover, pre-pregnancy BMI was associated with foetus percentage of PUFAs (Coeff: -0.172; p = 0.009), omega 6 (Coeff: -0.098; p = 0.015) and DHA (Coeff: -0.0285; p = 0.036), even after adjusting for maternal lipids. Our findings show that maternal GWG affects maternal but not foetal lipid profile, differently from pre-pregnancy BMI, which influences both.
- Published
- 2016
- Full Text
- View/download PDF
162. Chronic diarrhea in a patient with severe vitamin B12 deficiency: a rare clinical manifestation.
- Author
-
Mirijello A, Vallone C, De Cosmo S, Landolfi R, and Addolorato G
- Subjects
- Aged, Chronic Disease, Female, Humans, Severity of Illness Index, Vitamin B 12 Deficiency complications, Diarrhea etiology, Vitamin B 12 Deficiency diagnosis
- Published
- 2016
- Full Text
- View/download PDF
163. Phylogenetic and Metabolic Tracking of Gut Microbiota during Perinatal Development.
- Author
-
Del Chierico F, Vernocchi P, Petrucca A, Paci P, Fuentes S, Praticò G, Capuani G, Masotti A, Reddel S, Russo A, Vallone C, Salvatori G, Buffone E, Signore F, Rigon G, Dotta A, Miccheli A, de Vos WM, Dallapiccola B, and Putignani L
- Subjects
- Humans, Infant, Newborn, Magnetic Resonance Spectroscopy, Intestines microbiology, Microbiota, Phylogeny
- Abstract
The colonization and development of gut microbiota immediately after birth is highly variable and depends on several factors, such as delivery mode and modality of feeding during the first months of life. A cohort of 31 mother and neonate pairs, including 25 at-term caesarean (CS) and 6 vaginally (V) delivered neonates (DNs), were included in this study and 121 meconium/faecal samples were collected at days 1 through 30 following birth. Operational taxonomic units (OTUs) were assessed in 69 stool samples by phylogenetic microarray HITChip and inter- and intra-individual distributions were established by inter-OTUs correlation matrices and OTUs co-occurrence or co-exclusion networks. 1H-NMR metabolites were determined in 70 stool samples, PCA analysis was performed on 55 CS DNs samples, and metabolome/OTUs co-correlations were assessed in 45 CS samples, providing an integrated map of the early microbiota OTUs-metabolome. A microbiota "core" of OTUs was identified that was independent of delivery mode and lactation stage, suggesting highly specialized communities that act as seminal colonizers of microbial networks. Correlations among OTUs, metabolites, and OTUs-metabolites revealed metabolic profiles associated with early microbial ecological dynamics, maturation of milk components, and host physiology.
- Published
- 2015
- Full Text
- View/download PDF
164. Effects of unilateral ovariectomy on female fertility outcome.
- Author
-
Bellati F, Ruscito I, Gasparri ML, Antonilli M, Pernice M, Vallone C, Morano G, Chirletti P, Berloco PB, and Panici PB
- Subjects
- Abortion, Spontaneous epidemiology, Adult, Appendectomy statistics & numerical data, Birth Rate, Cholecystectomy statistics & numerical data, Female, Humans, Italy epidemiology, Ovariectomy statistics & numerical data, Patient Selection, Pregnancy, Pregnancy, Ectopic epidemiology, Reproductive Techniques, Assisted, Retrospective Studies, Stillbirth epidemiology, Treatment Outcome, Fertility, Ovariectomy methods
- Abstract
Purpose: To compare the fertility outcome among women subjected to unilateral ovariectomy and other abdominal or non-gynaecologic pelvic surgery., Methods: In this retrospective cohort study, 113 fertile women, surgically treated between 1990 and 2001 at Sapienza University of Rome with unilateral ovariectomy (UO), appendectomy (AP) or cholecystectomy (CO) for benign disease, were analysed for fertility outcome. Patients with assessed pre-surgical fertility defects, previous abdominal or pelvic surgeries and post-surgical contraception were not included., Results: Thirty-five women underwent UO, 39 were subjected to AP and 39 were treated with CO. After a minimum 10-year post-surgical interval, the overall number of successful pregnancies was 75. The rate of women who experienced at least one post-operative successful pregnancy was: 48.5 % in UO, 41 % in AP and 53.8 % in CO (UO vs. AP, P = 0.55; UO vs. CO, P = 0.99; AP vs. CO, P = 0.53). One patient (2.8 %) in UO, one patient (2.6 %) in AP and two patients (5.1 %) in CO underwent Assisted Reproductive Technology to become pregnant. The rate of women who reported at least one miscarriage was: 10/35 (28.5 %) in UO, 11/39 (28.2 %) in AP, 12/39 (30.8 %) in CO (UO vs. AP, P = 0.93; UO vs. CO, P = 0.89; AP vs. CO, P = 0.81). One ectopic pregnancy was reported in CO group and one stillbirth occurred in one AP patient., Conclusions: No statistical difference in terms of post-operative fertility outcome between patients subjected to UO, AP or CO was found, thus allowing to suppose that the removal of one ovary does not significantly worsen the female fertility outcome respect to other abdominal or pelvic procedures.
- Published
- 2014
- Full Text
- View/download PDF
165. Short-term surviving sirenomelia neonate followed by a complex mesodermal malformation in a sibling.
- Author
-
Rigon G, Vallone C, Silvestri E, and Signore F
- Subjects
- Abnormalities, Multiple diagnosis, Abortion, Induced, Adult, Cesarean Section, Female, Humans, Infant, Newborn, Kidney diagnostic imaging, Magnetic Resonance Imaging, Pregnancy, Prenatal Diagnosis, Time Factors, Ultrasonography, Ectromelia diagnosis, Kidney abnormalities, Mesoderm abnormalities
- Published
- 2013
- Full Text
- View/download PDF
166. Anomalous ovarian artery vascularisation of a large uterine fibroid: successful embolisation.
- Author
-
Riu P, Vallone C, Rigon G, and Signore F
- Subjects
- Acrylic Resins therapeutic use, Angiography, Arteries, Female, Gelatin therapeutic use, Humans, Leiomyoma diagnostic imaging, Middle Aged, Ovary blood supply, Uterine Neoplasms diagnostic imaging, Embolization, Therapeutic, Leiomyoma blood supply, Leiomyoma therapy, Uterine Neoplasms blood supply, Uterine Neoplasms therapy
- Published
- 2013
- Full Text
- View/download PDF
167. Antiretroviral therapeutic drug monitoring in HIV-infected pregnant women: maternal immunovirological outcome at delivery and during the 18 month follow-up period.
- Author
-
Nicastri E, Ivanovic J, Signore F, Tempestilli M, Bellagamba R, Viscione M, Pisani G, Vallone C, Tommasi C, Gallo AL, De Nardo P, Pucillo PL, and Narciso P
- Subjects
- Adult, CD4 Lymphocyte Count, Female, Follow-Up Studies, HIV Seropositivity drug therapy, HIV-1 drug effects, Humans, Infant, Infant, Newborn, Longitudinal Studies, Male, Pregnancy, Pregnancy Complications, Infectious drug therapy, Pregnancy Outcome, Prospective Studies, Treatment Outcome, Viral Load, Anti-HIV Agents pharmacology, Antiretroviral Therapy, Highly Active, Drug Monitoring, HIV Seropositivity immunology, HIV-1 immunology, Pregnancy Complications, Infectious immunology, Pregnancy Complications, Infectious virology
- Abstract
No data are available on the long-term immunovirological outcome of HIV-positive pregnant women experiencing sub-therapeutic antiretroviral drug (ARV) concentrations during pregnancy. The objective of our study was to assess the long-term virological outcome in pregnant women treated with HAART. A prospective, multi-center study enrolled 60 HIV-infected pregnant women stratified into 3 groups according to the response to HAART. Group A, women successfully treated with HAART; Group B, women with confirmed virological failure during HAART; Group C, women successfully treated with HAART during pregnancy for prevention of vertical transmission only. Smoking, alcohol use, low adherence to therapy, and increased viral load at delivery were significantly associated to virological failure at univariate analysis. At multivariate regression analysis, only adherence to therapy was reported as an independent variable related to the virological response (p < 0.001). Virological failure during follow-up was reported in 2 (25.0%) of the 8 women with sub therapeutic Ctrough and in 4 of the 33 (12.1%) women with therapeutic Ctrough (p=0.33). In group C, the viro-immunological set points during follow-up did not differ from those observed before HAART initiation. No significantly increased rate of virological failure after delivery was reported in women with sub-therapeutic ARV concentrations during pregnancy and long-term follow-up. The long-term virological outcome was independently associated to reduced adherence to therapy. Evaluation of the clinical impact of the low plasma ARV concentrations during pregnancy on the long-term virological outcome deserves further larger studies.
- Published
- 2012
- Full Text
- View/download PDF
168. Maternal factors pre- and during delivery contribute to gut microbiota shaping in newborns.
- Author
-
Rigon G, Vallone C, Lucantoni V, and Signore F
- Subjects
- Animals, Animals, Newborn, Female, Humans, Infant, Newborn, Mice, Pregnancy, Biota, Delivery, Obstetric, Gastrointestinal Tract microbiology, Microbiota
- Published
- 2012
- Full Text
- View/download PDF
169. Pregnancy in HIV-positive patients: effects on vaginal flora.
- Author
-
Vallone C, Rigon G, Lucantoni V, Putignani L, and Signore F
- Subjects
- Female, Humans, Pregnancy, Risk Factors, Vaginosis, Bacterial microbiology, HIV Infections complications, Pregnancy Complications, Infectious microbiology, Vagina microbiology, Vaginosis, Bacterial complications
- Abstract
A high proportion of HIV-infected pregnant women present pathogenic organisms in their lower genital tract. This has been associated with the development of postpartum morbility, HIV transmission to the partner and offspring, and other gynaecological conditions, such as cervical dysplasia or cancer. Vaginal flora alterations can range from 47% in Western countries to 89% in Africa in pregnant HIV-positive patients, much higher than about 20% of the general population. Pathogen organism retrieval is high. As peripartum complications due to vaginal infections seem higher in HIV-positive patients, accurate investigation and treatment of such infections are strongly mandatory.
- Published
- 2012
- Full Text
- View/download PDF
170. Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety.
- Author
-
Ivanovic J, Bellagamba R, Nicastri E, Signore F, Vallone C, Tempestilli M, Tommasi C, Mazzitelli L, and Narciso P
- Subjects
- Adult, CD4 Lymphocyte Count, Darunavir, Drug Administration Schedule, Drug Therapy, Combination, Female, HIV Infections immunology, HIV Infections virology, HIV Protease Inhibitors administration & dosage, Humans, Infant, Newborn, Pregnancy, Pregnancy Complications, Infectious metabolism, Pregnancy Complications, Infectious virology, Ritonavir administration & dosage, Sulfonamides administration & dosage, Treatment Outcome, Viral Load, HIV Infections drug therapy, HIV Protease Inhibitors pharmacokinetics, HIV-1 drug effects, Pregnancy Complications, Infectious drug therapy, Ritonavir pharmacokinetics, Sulfonamides pharmacokinetics
- Published
- 2010
- Full Text
- View/download PDF
171. Nephron-sparing surgery: our experience in open and laparoscopic approach in 254 cases.
- Author
-
Rozanec JJ, Ameri C, Holst P, Featherston M, Vallone C, Atchabahián P, Hernández A, Nolazco A, Ares J, and Mazza O
- Subjects
- Female, Humans, Male, Middle Aged, Nephrons, Retrospective Studies, Kidney Neoplasms surgery, Laparoscopy, Nephrectomy methods
- Abstract
Objectives: The majority of renal cell carcinomas are now incidentally detected as small renal masses in asymptomatic patients due to the widespread use of ultrasound and new improved noninvasive abdominal imaging modalities. Nephron-sparing surgery is the treatment of choice for patients with small renal masses in presence of normal contralateral kidney or in presence of an anatomic or functional solitary kidney. We reviewed retrospectively our experience in open and laparoscopic partial nephrectomy., Methods: The records for all patients who underwent nephron-sparing surgery for a renal mass since 1995 at British Hospital of Buenos Aires and Hospital Aleman and since 2000 at Hospital Universitario Austral were reviewed. The most relevant data of 246 patients were collected, with special focus on demographic data, operative details, pathology results, complications and outcome in cancer control., Results: We have performed 254 nephron-sparing surgeries. Open partial nephrectomy was performed in 220 procedures and the laparoscopic partial nephrectomy since 2001 in 34 patients. The indication was elective or relative in 236 patients with 8 patients with bilateral tumors and 18 tumors in a solitary kidney. The pedicle was clamped in 168 procedures with hypothermia in 43 patients. Mean ischemia time was 24.7 minutes. Average tumor size was 3.49 cm. The pathologic findings demonstrate a carcinoma in 193 cases and benign lesions in 61 patients (24%). One patient presented a positive surgical margin in the pathologic examination, but subsequent nephrectomy was negative for residual tumor. One patient presented a pseudo-tumoral mass on follow-up on CT scan and MRI, but nephrectomy was negative for residual tumor. There were postoperative complications in 20 patients (7.9 %). Oncologic follow up was available in 84% of the patients for an average of 46.6 months showing progression with metastasis in 8 patients. Local recurrence was observed in 4 patients (2%). One patient developed a tumor in the contralateral kidney 20 months after partial nephrectomy and another one 10 years later. The cancer specific survival and overall survival rates were 98 % and 95% respectively. In the last year the laparoscopic approach duplicated the indications of all previous years., Conclusions: Open partial nephrectomy is considered nowadays the gold standard treatment of small renal masses, and in our experience it is a safe and effective technique of treatment of these tumors. The evolution of the technology and the acquirement of laparoscopic skills allow us in selected cases to duplicate the open approach in a laparoscopic way, obtaining similar results.
- Published
- 2010
172. A dramatic storm of idiopathic ventricular fibrillation.
- Author
-
Allocca G, Vallone C, Nucifora G, Miani D, Facchin D, and Proclemer A
- Subjects
- Bundle-Branch Block complications, Female, Humans, Middle Aged, Purkinje Fibers metabolism, Ventricular Fibrillation etiology, Bundle-Branch Block physiopathology, Hypocalcemia complications, Ventricular Fibrillation physiopathology
- Published
- 2009
- Full Text
- View/download PDF
173. [Uretero-vescical anastomosis during kidney transplantation. Preliminary results of two surgical techniques].
- Author
-
Adani GL, Baccarani U, Lorenzin D, Tulissi P, Montanaro D, Gropuzzo M, Vallone C, Risaliti A, Bresadola V, and De Anna D
- Subjects
- Anastomosis, Surgical adverse effects, Anastomosis, Surgical methods, Female, Humans, Male, Middle Aged, Postoperative Complications epidemiology, Prospective Studies, Kidney Transplantation methods, Ureter surgery, Urinary Bladder surgery
- Abstract
Aim: The most frequent urologic complications after renal transplantation involve the uretero-vescical anastomosis (leakage, stenosis, and reflux), with a frequency of 1% to 30% in different series., Methods: We present our results in a prospective randomized trial performed from October 2004 to September 2005, in a cohort of 36 patients, who underwent renal transplantation from cadaveric donor at our institution. A uretero-vescical anastomosis according to Lich-Gregoir was used in 18 cases (group A), whereas an anastomosis according to Knechtle was performed in other 18 patients (group B), respectively. The groups were comparable for donors and recipients characteristics. The mean donor age was 46.3 years vs 44.9 years, and the mean duration of cold ischemia was 1 086+/-296 min vs 1 100+/-381 min for group A and for group B respectively. The mean recipient age was 47.5 years vs 46.1 for group A and group B, respectively., Results: No differences were evidenced between the two uretero-vescical anastomosis in term of surgical complications, infections or patient and graft survival at one year of follow-up. Stenosis and leakage involved 2 patients for each group respectively. Numbers of infections, days of antibiotic therapy were similar between the two groups., Conclusion: Our early experience does not evidence differences between the two types of uretero-vescical anastomosis.
- Published
- 2007
174. Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients.
- Author
-
Messa P, Vallone C, Mioni G, Geatti O, Turrin D, Passoni N, and Cruciatti A
- Subjects
- Adult, Aged, Calcifediol blood, Calcitonin blood, Calcitriol blood, Calcium Gluconate administration & dosage, Edetic Acid administration & dosage, Glomerular Filtration Rate, Humans, Hyperparathyroidism, Secondary etiology, Kidney Failure, Chronic blood, Kidney Failure, Chronic complications, Kinetics, Male, Middle Aged, Parathyroid Hormone blood, Calcium blood, Kidney Failure, Chronic physiopathology, Parathyroid Hormone metabolism
- Abstract
Secondary hyperparathyroidism (SHP) is a well documented finding even in the early stages of chronic renal failure (CRF). A sigmoidal relationship, fitting a four parameter model, links PTH secretion rate and calcium concentration changes. To our knowledge, PTH secretory parameters have only been studied in uremic patients who are in dialysis treatment. As a result of these studies, a possible role for derangement in setpoint values (that is, the serum calcium concentration corresponding to the mid-range value on the sigmoidal curve) has been suggested in the pathogenesis of SHP in CRF. Our study was undertaken to gain insight into the calcium-PTH relationship curve in the first course of CRF and to assess whether a change in any of the secretory parameters is related to the beginning of SHP. We studied 27 male renal patients with a variable degree of renal function (creatinine clearance 12 to 164 ml/min) and 9 control subjects. In all patients and controls the following parameters were evaluated: (1) basal 1,25(OH)2 vitamin D, 25(OH)vitamin D, calcitonin (CT), intact PTH; (2) GFR by Cr51EDTA clearance; (3) the sigmoidal PTH-ionized calcium relation curve, by means of a hypocalcemic stimulating test (Na2-EDTA 37 mg/kg body weight/2 hr) and a hypercalcemic test (Ca gluconate giving 8 mg/kg of body weight/2 hr of Ca element), performed on two consecutive days.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1994
- Full Text
- View/download PDF
175. Paradoxical effects of cardiac arrest by multidose potassium cardioplegia on myocardial lysosome integrity and phospholipid content.
- Author
-
Ambrosio G, Pellegrino A, Cappelli-Bigazzi M, Perrone-Filardi P, Vallone C, Lepore S, Chiariello M, and Chiariello L
- Subjects
- Acid Phosphatase metabolism, Animals, Glucuronidase metabolism, Male, Rats, Rats, Inbred Strains, Cardioplegic Solutions pharmacology, Heart Arrest, Induced, Liposomes metabolism, Myocardium metabolism, Phospholipids metabolism, Potassium pharmacology
- Abstract
Multidose potassium cardioplegia is known to result in greater preservation of myocardial ATP content and better recovery of function as compared to cardiac arrest induced by aortic clamping. The present study was undertaken to assess the effects of this procedure on biochemical markers of tissue damage. Rat hearts undergoing either multidose cardioplegia or ischemic cardiac arrest were maintained at 18 degrees C for 1 or 2 hr and processed without reperfusion. Control hearts were processed at time zero. The activity of two lysosomal enzymes (beta-glucuronidase and acid phosphatase), as well as membrane phospholipid content, was measured in cardiac homogenates. One hour of arrest by either technique did not induce significant changes in these parameters. Two hours of arrest affected lysosomal integrity, as indicated by release of lysosomal enzymes into the cytosol. Soluble acid phosphatase activity averaged 44.7 +/- 1.3 mU/mg of protein in the hearts processed after 2 hr of cardioplegic arrest, and was significantly higher than that of control hearts (12.3 +/- 3.8 mU/mg of protein; P less than 0.01) and that of hearts subjected to 2 hr of ischemic arrest (29.2 +/- 4.5 mU/mg of protein; P less than 0.01 vs cardioplegic arrest; P less than 0.01 vs controls). Phospholipid content in hearts subjected to 2 hr of cardioplegic arrest was lower than in controls (0.49 +/- 0.06 micrograms Pi/mg of protein vs 0.76 +/- 0.03 micrograms Pi/mg of protein; P less than 0.01). In conclusion, 2 hr of hypothermic cardiac arrest was associated with biochemical indices of tissue damage.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1990
- Full Text
- View/download PDF
176. [Mepindolol reduction of the degradation of phospholipids and the necrosis induced by myocardial ischemia].
- Author
-
Ambrosio G, Cappelli Bigazzi M, Perrone Filardi P, Pellegrino A, Vallone C, and Chiariello M
- Subjects
- Adrenergic beta-Antagonists pharmacology, Animals, Creatine Kinase metabolism, Hemodynamics drug effects, Male, Myocardial Infarction enzymology, Myocardial Infarction metabolism, Myocardial Infarction physiopathology, Pindolol pharmacology, Pindolol therapeutic use, Rats, Rats, Inbred Strains, Adrenergic beta-Antagonists therapeutic use, Myocardial Infarction drug therapy, Phospholipids metabolism, Pindolol analogs & derivatives
- Abstract
Mepindolol is a newly developed beta-adrenergic blocking agent, which differs from other available beta-blockers in its ability to counteract the chronotropic effect of catecholamines without depressing myocardial contractility. This study was designed to assess whether mepindolol administration is effective in reducing infarct size. Accordingly, 53 rats were randomly assigned to 3 groups: group 1 (n = 16) underwent coronary artery occlusion without receiving any treatment, and was used as control; group 2 (n = 19) was treated with mepindolol (1 mg/kg s.c.) 5 min and every 8 hours after occlusion, for 48 hours; group 3 (n = 18) underwent a sham-operation. No difference in mortality was found among groups. The animals were sacrificed 48 hours after occlusion and the left ventricle homogenized and centrifuged. Infarct size was calculated from the residual creatine phosphokinase activity, and found to average 52.4 +/- 7.8% (mean +/- SEM) of the left ventricle in control rats and 35.6 +/- 5.4% in treated rats (p less than 0.05), indicating a 32.1% reduction of infarct size. The phospholipid content of the supernatants was also measured: it averaged 0.08 microgram P/mg of protein in sham-operated rats and 0.61 + 0.04 micrograms P/mg of protein in control animals, showing that coronary ligation induced a degradation of myocardial phospholipids. Mepindolol-treated rats, however, showed a phospholipid concentration of 0.70 +/- 0.04 microgram P/mg of protein (p less than 0.05), suggesting that the drug was able to prevent ischemia-induced phospholipase activation.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1985
177. [Reduction of myocardial occlusion-reperfusion necrosis by the administration of a stable prostacyclin analog in the rabbit].
- Author
-
Golino P, Tritto I, Vallone C, Prota S, Salvatore M, and Chiariello M
- Subjects
- Animals, Coronary Disease complications, Coronary Disease diagnostic imaging, Coronary Disease pathology, Drug Evaluation, Preclinical, Heart diagnostic imaging, Iloprost, Myocardial Infarction etiology, Myocardial Infarction pathology, Myocardium pathology, Necrosis, Rabbits, Radionuclide Imaging, Technetium Tc 99m Aggregated Albumin, Cardiovascular Agents therapeutic use, Coronary Disease drug therapy, Epoprostenol therapeutic use, Myocardial Infarction prevention & control
- Published
- 1988
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.